Nutex Health (NUTX) provided the following response to a “misleading” short attack: “The Company is aware of the allegations made in a recent short seller report that attempts to call into question the Company’s collection process. As previously disclosed, Nutex Health has developed a robust internal process to code, bill and, if necessary after a federally mandated negotiation period, submit eligible medical claims to independent dispute resolution. The Company strongly disagrees with the allegations in the report and believes it is without merit. Further, the Company believes the report contains misrepresentations and conveys a misunderstanding of Nutex Health’s business. Nutex Health expects to provide related updates in its upcoming earnings release and Form 10-Q for the second quarter of 2025 due on or before August 14, 2025.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUTX:
- Blue Orca Capital short Nutex Health, says stock ‘un-investable’
- Nutex Health down 2% after Blue Orca publishes short report
- Clinigence Holdings Stockholders Approve Key Decisions
- Nutex Health COO Joshua DeTillio Resigns
- Nutex Health pullback due to ‘overhang’ of BCBS of Georgia suit, says Benchmark
